Profil
Richard A. Morgan is currently the Director at the American Society of Gene & Cell Therapy.
Prior to this, he was the Senior Vice President-Immunogenetics at Editas Medicine, Inc. from 2018 to 2021.
He received his undergraduate degree from Brandeis University and his doctorate from The Johns Hopkins University.
Aktive Positionen von Richard A. Morgan
| Unternehmen | Position | Beginn |
|---|---|---|
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Richard A. Morgan
| Unternehmen | Position | Ende |
|---|---|---|
| EDITAS MEDICINE, INC. | Corporate Officer/Principal | 01.02.2021 |
Ausbildung von Richard A. Morgan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Editas Medicine, Inc.
Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Commercial Services |
















